This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Pestka Biomedical Laboratories, Inc., Prolong Pharmaceuticals, LLC, Schering Corporation. Active years: 1998-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 6 
1 out of 1,829 
Years Active: 1998-2019
Title: Ronald G. Jubin: Pioneering Innovations in Hemoglobin and Interferon Research
Introduction
Ronald G. Jubin is a notable inventor based in Watchung, NJ, recognized for his innovative contributions in the field of biochemistry. With a total of three patents to his name, Jubin has made significant strides in the understanding and application of hemoglobin compositions and interferons.
Latest Patents
One of Jubin's latest patents focuses on hemoglobin compositions, particularly the formulation of PEGylated hemoglobin. This invention describes compositions that enhance oxygen or carbon monoxide transfer to tissues or red blood cells, thus providing valuable options for treating various diseases and injuries. The formulations developed by Jubin are noted for being virally inactivated and may include conjugated water-soluble polymers. Additionally, he has patented interferons originating from Rhesus and Cynomolgus species, detailing methods for their production and application in therapeutic settings.
Career Highlights
Throughout his career, Ronald G. Jubin has made impactful contributions while working at respected organizations such as Schering Corporation and Prolong Pharmaceuticals, LLC. His experience in these companies has not only broadened his expertise but also provided an environment conducive to innovation in biopharmaceutical research.
Collaborations
Jubin has collaborated with esteemed professionals in the field, including coworkers Abraham Abuchowski and Glenn Kazo. These collaborations have allowed Jubin to enhance his research and develop novel therapeutic solutions, expanding the scope of biomedicine.
Conclusion
With a focus on advancing medical science through innovative research, Ronald G. Jubin continues to leave his mark in the world of patents and inventions. His work with hemoglobin compositions and interferons showcases the potential for new therapies and enhances our understanding of critical biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile